188 related articles for article (PubMed ID: 33099003)
1. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
[TBL] [Abstract][Full Text] [Related]
2. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
[TBL] [Abstract][Full Text] [Related]
3. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
[TBL] [Abstract][Full Text] [Related]
4. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
[TBL] [Abstract][Full Text] [Related]
5. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
[TBL] [Abstract][Full Text] [Related]
6. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
7. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.
Xiao L; Patrick DM; Aden LA; Kirabo A
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():48-53. PubMed ID: 30278231
[TBL] [Abstract][Full Text] [Related]
9. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
10. Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.
Davies SS; May-Zhang LS; Boutaud O; Amarnath V; Kirabo A; Harrison DG
Pharmacol Ther; 2020 Jan; 205():107418. PubMed ID: 31629006
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry detection of isolevuglandin adduction to specific protein residues.
Charvet CD; Pikuleva IA
Methods Mol Biol; 2015; 1208():285-98. PubMed ID: 25323515
[TBL] [Abstract][Full Text] [Related]
12. Molecular Structures of Isolevuglandin-Protein Cross-Links.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
Chem Res Toxicol; 2016 Oct; 29(10):1628-1640. PubMed ID: 27599534
[TBL] [Abstract][Full Text] [Related]
13. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts.
Brame CJ; Salomon RG; Morrow JD; Roberts LJ
J Biol Chem; 1999 May; 274(19):13139-46. PubMed ID: 10224068
[TBL] [Abstract][Full Text] [Related]
14. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.
Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG
Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823
[TBL] [Abstract][Full Text] [Related]
15. Measurement of chronic oxidative and inflammatory stress by quantification of isoketal/levuglandin gamma-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry.
Davies SS; Amarnath V; Brame CJ; Boutaud O; Roberts LJ
Nat Protoc; 2007; 2(9):2079-91. PubMed ID: 17853863
[TBL] [Abstract][Full Text] [Related]
16. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
17. Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples.
Yermalitsky VN; Matafonova E; Tallman K; Li Z; Zackert W; Roberts LJ; Amarnath V; Davies SS
Anal Biochem; 2019 Feb; 566():89-101. PubMed ID: 30458125
[TBL] [Abstract][Full Text] [Related]
18. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
20. Isolevuglandin-protein adducts in oxidized low density lipoprotein and human plasma: a strong connection with cardiovascular disease.
Salomon RG; Kaur K; Batyreva E
Trends Cardiovasc Med; 2000 Feb; 10(2):53-9. PubMed ID: 11150730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
